Learn more

DEALLER STEPHEN F

Overview
  • Total Patents
    21
About

DEALLER STEPHEN F has a total of 21 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United Kingdom. Its main competitors in its focus markets pharmaceuticals are ATHENEX THERAPEUTICS LTD, WORLD MEDICINE ILAC SANAYI VE TICARET ANONIM SIRKETI and RANBAXY SIGNATURE LLC.

Patent filings in countries

World map showing DEALLER STEPHEN Fs patent filings in countries
# Country Total Patents
#1 United Kingdom 21

Patent filings per year

Chart showing DEALLER STEPHEN Fs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals

Focus technologies

Latest patents

Publication Filing date Title
GB0027808D0 The use of nucleic acid to maximise the sensitivity and specificity of detection methods exploiting antibodies or other binding entities
GB0027650D0 Labelled polyanionic dyes as a method to separate prion from normal protein
GB0004528D0 The use of polysulphate polyglycosides for treatment or prophylactic use in inflammatory bowel diseases of animals or humans
GB0003049D0 Polyanionic polyglycosides as histopatholoical stains for amycoid
GB0003048D0 The therapeutic use of polysulphonated polyglycosides or other polyanionic compounds in autism
GB0003050D0 Labelled polyanionic polyglywsidens as a method to separarte prion from normal forms of proteins
GB0001765D0 Polysulphonated polyglycosides,including heparin and pentosan polysulphate as treatments for autism
GB9927756D0 A highly sensitive and specific method for the indication of anigenic or chemically adherent biochemical sites using nucleic acid
GB9913249D0 A highly sensitive and specific method for the demonstration of antigenic or chemically adherent biochemical sites using nucleic acid
GB9816152D0 A specific and sensitive method for the seeking of the prion form of the prion protein in various fluids and tissues
GB9713873D0 The formation of a specific test for amyloid
GB9700556D0 A specific and sensitive method for the diagnosis of transmissible spongiform encehalopathy (TSE)
GB9622211D0 Specific chemicals active against prion infection
GB9424725D0 Gene therapy in the treatment of Alzheimer's disease (AD)or any of the transmissible spongiform encephalopathies (TSEs)
GB9325831D0 Specefic chemicals active against prion infection
GB9210783D0 The extraction and use of chemicals from the common daisy (bellis perennis)and other specific plants for the treatment of human and animal illness
GB9122094D0 Pharmaceutical chemicals usable for diagnosis and for treatment of prion linked disease
GB8912406D0 Chemical indicator of butyryl esterase activity